Ozempic and Wegovy: Effective Weight Loss Solutions

Friday, 13 September 2024, 08:00

Ozempic and Wegovy (semaglutide) show significant effectiveness in weight loss, outperforming Saxenda (liraglutide). A recent study indicates that over 60% of patients using Ozempic achieved a weight loss of 10% or more. This post explores the findings and implications for obesity treatment.
Healthday
Ozempic and Wegovy: Effective Weight Loss Solutions

Effective Weight Loss: Ozempic vs Saxenda

In a recent study published in JAMA Network Open, researchers discovered that Ozempic and Wegovy (semaglutide) significantly outperform Saxenda (liraglutide) in promoting weight loss. Specifically, 61% of participants using semaglutide achieved a weight loss of 10% or more over one year, compared to only 29% for those on liraglutide.

Study Insights

The research analyzed data from nearly 3,400 adults treated between 2015 and 2022, revealing that long-term success in weight reduction varied greatly with different medications. Semaglutide has received approvals for treating diabetes and obesity, offering remarkable benefits such as improved blood sugar levels and potential remission for diabetes cases.

  • Results highlighted that higher doses of semaglutide led to greater weight loss.
  • Factors affecting weight loss included adherence to the medication and initial BMI.
  • With real-world data, patients can be better informed about expectations regarding weight loss with GLP-1 medications.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe